All Stories

  1. Impact of Policy on using the Disease Risk Score

    Article • Journal of Comparative Effectiveness Research, November 2015, Future Medicine

    Dr Mina Tadrous

  2. Variation in the days supply field for osteoporosis medications in Ontario

    Article • Archives of Osteoporosis, March 2013, Springer Science + Business Media

    Dr Mina Tadrous

  3. Pegfilgrastim: a review of the pharmacoeconomics for chemotherapy-induced neutropenia

    Article • Expert Review of Pharmacoeconomics & Outcomes Research, December 2012, Taylor & Francis

    Dr Mina Tadrous

  4. Disease risk score as a confounder summary method: systematic review and recommendations

    Article • Pharmacoepidemiology and Drug Safety, November 2012, Wiley

    Dr Mina Tadrous

  5. Does depression lead to influenza? — A systematic literature analysis

    Article • Journal of Affective Disorders, April 2012, Elsevier

    Dr Mina Tadrous

  6. Establishing a Complete Drug Information Triad: Academic, Industry, and Hospital Training

    Article • Drug Information Journal, September 2011, SAGE Publications

    Dr Mina Tadrous

  7. Overactive Bladder Drugs and Constipation: A Meta-Analysis of Randomized, Placebo-Controlled Trials

    Article • Digestive Diseases and Sciences, July 2010, Springer Science + Business Media

    Dr Mina Tadrous

  8. First renin inhibitor, aliskiren, for the treatment of hypertension

    Article • September 2008, Springer Science + Business Media

    Dr Mina Tadrous

  9. T1311 Gastrointestinal Tolerability of Anticholinergic Drugs for Treatment of Overactive Bladder Compared to Placebo: A Systematic Review and Meta-Analysis of 43 Studies

    Article • Gastroenterology, April 2008, Elsevier

    Dr Mina Tadrous

  10. Effects of dextromethorphan on in vitro contractile responses of mouse and rat urinary bladders

    Article • Neurourology and Urodynamics, January 2006, Wiley

    Dr Mina Tadrous